T. E. Craven
Publications While At Healthpartners
Longitudinal changes in dietary fat intake and associated changes in cardiovascular risk factors in adults with type 2 diabetes: the ACCORD trial
Diabetes Research and Clinical Practice.
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients
Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience
Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Lancet (London, England).
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study
BMJ (Clinical research ed.).
Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis
Journal of the American Dietetic Association.
Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]
Reversibility of fenofibrate-induced renal function impairment in ACCORD type 2 diabetic participants [abstract]
Microvascular effects of intensive blood pressure control and its relation to glycemic control in the ACCORD blood pressure trial [presentation]
Map of science